跳至主要内容
临床试验/NCT03060018
NCT03060018已完成不适用

Agreement of Transcutaneous Partial Oxygen and Carbon Dioxide Pressure With Arterial and Capillary Blood Gas Values. A Single Centre Prospective Non-randomized Trial in Critically Ill Neonates.

Vera Bernet, MD2 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2017年8月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
113
试验地点
2
主要终点
Bias and precision of the transcutaneous oxygen and carbon dioxide measurements

研究概览

简要总结

Partial blood oxygen and carbon dioxide pressures obtained in critical ill neonates by transcutaneous sensors will be compared to respective values obtained by medically indicated arterial and capillary blood gas analyses. The influence of blood withdrawal method, sensor operational temperature and application time, presence of cyanotic heart malformations and/or intra or extra cardiac right to left shunt, vasoactive drugs, elevated non-conjugated bilirubin, and skin and soft tissue oedema, skin colour and perfusion conditions will be elucidated as well as sensor's safety. Study duration will be 48 hours with sensors applied and additional 4 hours of further surveillance for thermal injury.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
— 至 10 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Late premature or term birth newborn infants (34 0/7 until 43 6/7 weeks gestational age (GA)).
  • Age between first day of life and 43 6/7 weeks postmenstrual age.
  • Ability of care taker to understand verbal and written instructions and informed consent in German.

排除标准

  • Care taker unable or unwilling to give written informed consent in German.
  • Care taker not understanding German and without a family member able to translate.
  • Written informed consent cannot be obtained for any other reason.

研究组 & 干预措施

All included patients

Experimental

All included patients will undergo the intervention of transcutaneous sensor placement

干预措施: Sentec (SenTec) Digital Monitoring System with OxiVenT Sensor (Device)

结局指标

主要结局

Bias and precision of the transcutaneous oxygen and carbon dioxide measurements

时间窗: 52 hours

Agreement of transcutaneous measurements with capillary and arterial blood gas values at two operational sensor temperatures (42 and 43°C).

次要结局

  • Bias and precision of oxygen and carbon dioxide transcutaneous measurements under the influence of elevated indirect bilirubin(52 hours)
  • Agreement of partial transcutaneous oxygen and carbon dioxide pressures with arterial and capillary values in children with echocardiographically determined congenital cyanotic heart disease and/or intra or extra cardiac right to left shunt(52 hours)
  • Bias and precision of oxygen and carbon dioxide transcutaneous measurements under the influence of vasoactive drugs (Adrenalin, Noradrenalin, Dopamine, Dobutamine, Vasopressin, Milrinone)(52 hours)
  • Bias and precision of the oxygen and carbon dioxide transcutaneous measurements over time at one anatomical site with determination of technical drift and physiological drift(52 hours)
  • Bias and precision of transcutaneous partial oxygen and carbon dioxide pressure measurements with changing peripheral perfusion(52 hours)
  • Bias and precision of transcutaneous partial oxygen and carbon dioxide pressure measurements with different skin colour types(52 hours)
  • Safety of OxiVenT sensor: Appearance of signs of thermal injury (redness, blisters, necrosis) under application of transcutaneous sensor temperatures of 42 and 43°C(52 hours)
  • Bias and precision of transcutaneous partial oxygen and carbon dioxide pressure measurements in patients with skin and soft tissue oedema(52 hours)

研究者

发起方
Vera Bernet, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Vera Bernet, MD

Senior Consultant Pediatric Intensive Care

University Children's Hospital, Zurich

研究点 (2)

Loading locations...

相似试验